7.3 Contraindications and Contraception
Key Takeaways
- The few true infant-side and maternal-side contraindications include infant classic galactosemia, maternal HIV without sustained viral suppression (high-resource settings), HTLV-1/2, active untreated TB until ~2 weeks of treatment, herpes lesions on the breast, and certain chemotherapy or radioisotopes.
- TB and breast herpes are positional/temporary: expressed milk or the unaffected breast can still be used because the issue is direct contact, not the milk itself.
- Progestin-only methods are preferred during lactation; estrogen-containing (combined) contraceptives can reduce supply, especially in the early weeks.
- The Lactational Amenorrhea Method works only when all three criteria hold: under 6 months postpartum, amenorrheic, and exclusively (or nearly) breastfeeding — and is then about 98% effective.
- Most maternal conditions and medications are NOT contraindications, so the exam-correct instinct is to keep breastfeeding unless one of the short-list exceptions applies.
A Short List, Tested Hard
The whole of Pharmacology and Toxicology rewards restraint, and nowhere more than here. The IBCLC must hold a short, memorized list of true contraindications and recognize that almost everything else — mastitis, a cold, an L2 antibiotic, a needed antidepressant — is compatible. Exam items bury one real contraindication among several compatible conditions, or present a temporary/positional issue and tempt you to call it absolute.
True Contraindications
Group them into infant-side and maternal-side, and tag each as absolute, temporary, or positional.
Infant-side
- Classic galactosemia — the only infant metabolic absolute contraindication. The infant cannot metabolize galactose; since lactose is the main carbohydrate in human milk, the baby requires a galactose-free formula. (Some other inborn errors, e.g., PKU, allow partial breastfeeding with monitored levels — galactosemia does not.)
Maternal-side
- HIV — in high-resource settings such as the United States, maternal HIV without sustained viral suppression contraindicates breastfeeding because the virus transmits through milk. Context matters: where replacement feeding is not safe (many low-resource settings), the WHO supports breastfeeding on antiretroviral therapy because the danger of not breastfeeding is greater.
- HTLV-1 / HTLV-2 (human T-cell lymphotropic virus) — an absolute contraindication due to milk-borne transmission.
- Active, untreated tuberculosis — a temporary contraindication to direct breastfeeding (droplet transmission). After about 2 weeks of treatment and documented non-infectiousness, the mother may nurse; importantly, expressed milk can be given throughout because TB does not pass through milk itself.
- Active herpes (HSV) lesion on the breast — a positional restriction: feed from the unaffected breast and cover or avoid the lesion until healed.
- Certain chemotherapy / antimetabolites and radioactive isotopes — require temporary or permanent interruption; for a diagnostic radioisotope, the mother pumps and discards for the isotope-specific interval, then resumes.
- Active illicit drug use (cocaine, PCP, etc.) — a contraindication during use (covered in the substances section).
Most Conditions Are NOT Contraindications
For contrast, these common scenarios do not stop breastfeeding: mastitis (continue feeding/draining), most maternal infections (cold, flu, COVID with precautions), hepatitis B (with infant immunoprophylaxis) and hepatitis C, an L1-L3 medication, and a single screening X-ray or routine MRI/CT contrast. When the stem lists one of these, the answer is to continue.
Contraception During Lactation
Contraceptive counseling is a recurring exam theme because the wrong method can sabotage supply. The governing rule: estrogen can reduce milk supply, especially in the early weeks, so progestin-only or non-hormonal methods are preferred.
| Method | Effect on supply | Timing / notes |
|---|---|---|
| Progestin-only pill (POP) / mini-pill | Minimal | Preferred hormonal option; safe to start early postpartum |
| Progestin implant / DMPA injection | Minimal | Compatible; some clinicians wait a few weeks to be cautious |
| Levonorgestrel IUD (hormonal) | Minimal | Preferred LARC; often placed at the postpartum visit (or immediately postpartum per protocol) |
| Copper IUD | None (non-hormonal) | Fully compatible; no hormonal supply effect |
| Barrier methods / condoms | None | Always compatible |
| Combined estrogen-progestin (COC, patch, ring) | Can REDUCE supply | Avoid early; if used later, choose lowest estrogen and monitor supply |
| Lactational Amenorrhea Method (LAM) | Supports breastfeeding | Effective only if all three criteria are met (below) |
The LAM Criteria
LAM uses exclusive breastfeeding itself as contraception, and is about 98% effective — but only when all three conditions hold simultaneously:
- The infant is under 6 months old.
- The mother is amenorrheic (no menses returned after 56 days postpartum).
- The mother is exclusively or nearly exclusively breastfeeding (frequent day and night feeds, no long gaps, minimal supplementation).
If any criterion fails — the baby turns 6 months, menses return, or feeds become spaced/supplemented — LAM is no longer reliable and a backup method is needed.
Worked Example: A mother at her 6-week visit is breastfeeding exclusively, has had no period, and wants reliable contraception while protecting supply. Her clinician suggests a combined estrogen-progestin pill. The IBCLC, collaborating with the prescriber, notes that estrogen can lower supply in these early weeks and that this mother could rely on LAM now (under 6 months, amenorrheic, exclusive) while transitioning to a progestin-only method, levonorgestrel IUD, or copper IUD before any LAM criterion lapses. This protects both contraceptive efficacy and milk supply.
In-Text Recap
Memorize the short contraindication list — galactosemia (infant), and HIV (context-dependent), HTLV-1/2, untreated TB until treated, breast herpes lesion, and certain chemo/radioisotopes (maternal) — and tag each as absolute, temporary, or positional. For contraception, prefer progestin-only or non-hormonal methods because estrogen can cut supply, and apply all three LAM criteria before relying on it.
Contraindication Classification
| Contraindication | Side | Type | Key nuance |
|---|---|---|---|
| Classic galactosemia | Infant | Absolute | Needs galactose-free formula; permanent |
| HIV (no viral suppression) | Maternal | Setting-dependent | Contraindicated in high-resource settings; WHO supports BF on ART where formula is unsafe |
| HTLV-1 / HTLV-2 | Maternal | Absolute | Transmits via milk |
| Active untreated TB | Maternal | Temporary | Resume direct feeds after ~2 weeks of treatment; expressed milk OK meanwhile |
| HSV lesion on breast | Maternal | Positional | Feed from unaffected breast until healed |
| Chemo / radioisotopes | Maternal | Temporary/permanent | Pump and discard for the required interval |
Which of the following is a TEMPORARY (not permanent) contraindication where expressed milk may still be given to the infant?
A breastfeeding mother at 5 weeks postpartum wants hormonal contraception while protecting her milk supply. Which is the BEST choice?
Order these three LAM criteria as they are typically checked, then identify that ALL must be true. Put them in order: amenorrhea check, infant age check, feeding-exclusivity check.
Arrange the items in the correct order
A mother in the United States with HIV that is NOT virally suppressed asks about breastfeeding. The IBCLC should explain that: